SCHEMBL4066939

SCHEMBL4066939

CC(C)C1=CCC(C(C)C)=C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12815638 0.74
SCHEMBL6253503 0.74
SCHEMBL714754 0.74
SCHEMBL19221730 0.73
SCHEMBL31029915 0.72
SCHEMBL8730310 0.72
SCHEMBL18727570 0.72
SCHEMBL31029914 0.72
Hydrochloric Acid SCHEMBL887739 0.70
Hydrochloric Acid SCHEMBL887738 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024076047-A1 COMPOSITION FOR PLANT DISEASE CONTROL COMPRISING CULTURE FLUID OF STREPTOMYCES LYDICUS JCK-6019 STRAIN OR EXTRACT OF CULTURE FLUID OF STRAIN, PREPARATION METHOD THEREFOR, AND PLANT DISEASE CONTROL METHOD 전남대학교산학협력단 2024-04-11 WO claimed
WO-2024076047-A1 COMPOSITION FOR PLANT DISEASE CONTROL COMPRISING CULTURE FLUID OF STREPTOMYCES LYDICUS JCK-6019 STRAIN OR EXTRACT OF CULTURE FLUID OF STRAIN, PREPARATION METHOD THEREFOR, AND PLANT DISEASE CONTROL METHOD 전남대학교산학협력단 2024-04-11 WO disclosed
CN-107312045-A A kind of preparation method of substituted cyclopentadienyl metallocene compound 上海化工研究院有限公司 2017-11-03 CN disclosed
EP-1710247-B1 TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION IDEMITSU KOSAN CO (JP) 2009-10-21 EP disclosed
CN-101341176-A Ethylene polymer, catalyst for producing ethylene polymer, and method for producing ethylene polymer TOSOH CORP (JP) 2009-01-07 CN disclosed
US-7453005-B2 Transition metal compound and catalyst for olefin polymerization IDEMITSU KOSAN CO., LTD. (JP) 2008-11-18 US disclosed
US-20070161502-A1 Transition metal compound and catalyst for olefin polymerization IDEMITSU KOSAN CO., LTD. (JP) 2007-07-12 US disclosed
EP-1710247-A1 TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION IDEMITSU KOSAN CO., LTD. (JP) 2006-10-11 EP disclosed
EP-0926150-B1 Production of alkali metal cyclopentadienylides and production of dihalobis(eta-substituted-cyclopentadienyl) zirconium from alkali metal cyclopentadienylides HONSHU CHEMICAL IND (JP) 2005-09-07 EP disclosed
US-6046346-A Production of alkali metal cyclopentadienylide and production of dihalobis (η-substituted-cyclopentadienyl) zirconium from alkali metal cyclopentadienylide HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2000-04-04 US disclosed
CN-1246486-A Catalyst system based on fulvene metal compound BAYER AG (DE) 2000-03-08 CN disclosed
EP-0926150-A2 Production of alkali metal cyclopentadienylide and production of dihalobis(eta-substituted-cyclopentadienyl) zirconium from alkali metal cyclopentadienylide Honshu Chemical Industry Co. Ltd. (JP) 1999-06-30 EP disclosed
US-5708101-A METALLOCENES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161502-A1 Transition metal compound and catalyst for olefin polymerization PYM1, YBX1, SSB PTPN1 2757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.